A First in Human Study of AUR 103 Calcium to Evaluate Safety, Pharmacokinetics and Pharmacodynamics

Clinical trial NCT05607199 · TERMINATED

Trial details

NCT number: NCT05607199
Sponsor: Aurigene Discovery Technologies Limited
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Solid Tumor, Adult Acute Myeloid Leukemia Myelodysplastic Syndromes Non Hodgkin Lymphoma

Start date: 2022-09-16
Primary completion: 2024-11-27
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.